MiRNA-424-5p Suppresses Proliferation, Migration, and Invasion of Clear Cell Renal Cell Carcinoma and Attenuates Expression of O-GlcNAc-Transferase
Overview
Authors
Affiliations
MicroRNAs (miRNAs) are non-coding post-transcriptional regulators of gene expression that are dysregulated in clear cell renal cell carcinoma (ccRCC) and play an important role in tumor progression. Our prior work identified a subset of miRNAs in pT1 ccRCC tumors, including miR-424-5p, that are associated with an aggressive phenotype. We investigate the impact of this dysregulated miRNA and its protein target O-GlcNAc-transferase (OGT) to better understand the mechanisms behind aggressive stage I ccRCC. The ccRCC cell lines 786-O and Caki-1 were used to assess the impact of miR-424-5p and OGT. Cells were transfected with pre-miR-424-5p, a lentiviral anti-OGT shRNA, or were treated with the demethylating agent 5-Aza-2'-deoxycytidine. Cell proliferation was measured via MT cell viability assay. Cell migration and invasion were analyzed using Transwell assays. The expression of miR-424-5p was determined through qRT-PCR, while OGT protein expression was evaluated through Western blotting. The interaction between miR-424-5p and OGT was confirmed via luciferase reporter assay. The transfection of ccRCC cells with pre-miR-424-5p or anti-OGT shRNA significantly inhibited cell proliferation, migration, and OGT expression, while miR-424-5p also attenuated cell invasion. Addition of the demethylating agent significantly reduced cell proliferation, migration, invasion, and OGT expression, while significantly increasing the expression of miR-424-5p. Altogether, these findings suggest that epigenetic downregulation of miR-424-5p, which in turn augments OGT expression, contributes to the creation of aggressive forms of stage I ccRCC.
Esmaeili M, Smith D, Mead B Sci Rep. 2024; 14(1):31895.
PMID: 39738601 PMC: 11685716. DOI: 10.1038/s41598-024-83381-9.
Fei K, Zhang H, Zhang W, Liao C Reprod Sci. 2024; 31(11):3428-3439.
PMID: 38997540 DOI: 10.1007/s43032-024-01641-5.
Arderiu G, Civit-Urgell A, Diez-Caballero A, Moscatiello F, Ballesta C, Badimon L Cells. 2024; 13(6.
PMID: 38534357 PMC: 10969675. DOI: 10.3390/cells13060513.
Regulation of protein O-GlcNAcylation by circadian, metabolic, and cellular signals.
Liu X, Cai Y, Chiu J J Biol Chem. 2023; 300(2):105616.
PMID: 38159854 PMC: 10810748. DOI: 10.1016/j.jbc.2023.105616.
MEF2C and miR-194-5p: New Players in Triple Negative Breast Cancer Tumorigenesis.
Caetano S, Garcia A, Figueira I, Brito M Int J Mol Sci. 2023; 24(18).
PMID: 37762600 PMC: 10531597. DOI: 10.3390/ijms241814297.